Pathogenic mechanisms of neurodegenerative diseases: Amyotrophic lateral sclerosis;Mécanismes pathogéniques des maladies neurodégé nératives: L'exemple de la sclérose latérale amyotrophique

Revue Medicale Suisse

Volumn 2, Issue 64, 2006, Pages 1152-1157

  Kato, Ann ^a   Vingerhoets, François J G ^b   Magistris, Michel R ^a   Kuntzer, Thierry ^b   Burkhard, Pierre R ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN ALS2; SOMATOMEDIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; BRAIN NERVE CELL; DISEASE COURSE; GENETIC ANALYSIS; HUMAN; NEUROFILAMENT; OXIDATIVE STRESS; PREVALENCE; REVIEW; SYNAPTIC TRANSMISSION;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS;

EID: 33749250543     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Yoshida S, Mulder DW, Kurland LT, et al. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1964. Neuroepidemiology 1986;5:61-70.
2. Leigh PN, Swash M. Cytosketeal pathology in motor neuron disease. Adv Neurol 1991;56:115-24.
3. Gonatas NK, Stieber A, Mourelatos Z, et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol 1992;140:731-7.
4. Delisle MB, Carpenter S. Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J Neurol Sci 1984; 63:241-50.
5. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362:59-62.
6. Clement AM, Nguyen MD, Roberts EA, et al. Wild-type non neuronal cells extend survival of SODI mutant motor neurons in ALS mice. Science 2003;302:113-7.
7. Gong YH, Parsadanian AS, Andreeva A, et al. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 2000;20:660-5.
8. Lino MM, Schneider C, Caroni P. Accumulation of SODI mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 2002;22:4825-32.
9. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001;29:160-5.
10. Garcia ML, Lobsiger CS, Shah SB, et al. NF-M is an essential target for the myelin-directed «outside-in» signaling cascade that mediates radial axonal growth. J Cell Biol 2003;163:1011-20.
11. Kawamura Y, Dyck PJ, Shimono M, et al. Morphometric comparison of the vulnerability of peripheral motor and senory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1981;40:667-75.
12. Bruijn LI, Becher W, Lee MK, et al. ALS-linked SODI mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SODI-containing inclusions. Neuron 1997;18:327-38.
13. Al-Chalabi A, Andersen PM, Nilsson P, et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999;8:157-64.
14. DeJonghe P, Mersivanova I, Neils E, et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 2001;49:245-9.
15. Hafezparast M, Klocke R, Ruhrberg C, et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport Science 2003;300:808-12.
16. LaMonte BH, Wallace KE, Holloway BA, et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002;34:715-27.
17. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003;33:455-6.
18. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675-86.
19. Spreux-Varoquaux O, Bensimon G, Lacomblez L, et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: A reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 2002;193:73-8.
20. Rothstein JD, Van Kammen M, Levey AI, et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
21. Ralph GS, Radcliffe PA, Day DM, et al. Silencing mutant SODI using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 2005;93:106-19.
22. Raoul C, Abbas-Terki T, Bensadoun JC, et al. Lentiviral-mediated silencing of SODI through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005;11:423-8.
23. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci 2002;22:629-34.
24. Gage FH. Neurogenesis in the adult brain. J Neurosci 2002;22:612-3.